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Abstract
Skin that is exposed to radiation has an impaired ability to heal wounds. This is especially true for 
whole body irradiation, where even moderate non-lethal doses can result in wound healing 
deficits. Our previous attempts to administer dermal cells locally to wounds to correct radiation-
induced deficits were hampered by poor cell retention. Here we improve the outcome by using 
biodegradable fibrin microbeads (FMB) to isolate a population of mesenchymal marrow-derived 
stromal cells (MSC) from murine bone marrow by their specific binding to the fibrin matrix, 
culture them to high density in vitro and deliver them as MSC on FMB at the wound site. MSC are 
retained and proliferate locally and assist wounds gain tensile strength in whole body irradiated 
mice with or without additional skin only exposure. MSC-FMB were effective in 2 different 
mouse strains but were ineffective across a major histocompatability barrier. Remarkably, 
irradiated mice whose wounds were treated with MSC-FMB showed enhanced hair regrowth 
suggesting indirect effect on the correction of radiation-induced follicular damage. Further studies 
showed that additional wound healing benefit could be gained by administration of G-CSF and 
AMD3100. Collagen strips coated with haptides and MSCs were also highly effective in 
correcting radiation-induced wound healing deficits.
Introduction
There is growing concern about the dearth of medical countermeasures for the treatment of 
ionizing radiation injuries in the event of either a radiological or nuclear incident (Williams 
and McBride, 2011). This has led to many studies directed at correcting the acute radiation 
syndrome (ARS). Much is known about how different tissues individually respond to 
radiation but less about how damage to one tissue affects healing of another and how effects 
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
Corresponding author: William H. McBride, UCLA David Geffen School Medicine, Dept. Radiation Oncology, 10833 Le Conte 
Avenue Box 951714, B3-109 CHS Los Angeles, CA 90095-1714, USA. Phone: (310) 794-7051, Fax: (310) 206-1260, 
wmcbride@mednet.ucla.edu. 
Conflict of interest
The authors state no conflict of interest.
HHS Public Access
Author manuscript
J Invest Dermatol. Author manuscript; available in PMC 2013 August 01.
Published in final edited form as:
J Invest Dermatol. 2013 February ; 133(2): 553–561. doi:10.1038/jid.2012.326.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
are compounded by non-radiation injuries. The skin is particularly susceptible to 
compounded injuries.
In an ARS situation, rapid wound closure, re-epithelialization, and re-establishment of the 
skin tissue integrity are top clinical treatment priorities. These processes are compromised 
by irradiation, which seriously impedes the healing of physical or thermal skin wounds. 
Indeed radiation-impaired wound healing is a specific form of the general clinical challenge 
posed by non-healing wounds for which few effective treatment options are available 
(Olascoaga et al., 2008).
Healing of skin wounds involves complex, well-orchestrated interactions between different 
cell types and extracellular matrix materials (Wu et al., 2007b). After exposure to ionizing 
radiation, the time to expression of skin damage is determined by the slow turnover of 
dermal cells (Withers, 1967). However, trauma speed the proliferation rate of the affected 
cells and thereby greatly accelerates expression of any radiation-induced latent damage and 
wounded irradiated skin displays healing defects acutely (Gorodetsky et al., 1988). The dose 
and the body volume are critical variables. The dermis is relatively radiation resistant but 
local stem/progenitor skin cells can be damaged so that they fail to replace those lost 
through normal turnover or through physical or thermal injury. On the other hand, damage 
to the more sensitive hematopoietic system through whole or partial body radiation exposure 
can compromise the pool of bone marrow-derived cells that contribute to the healing 
process. This includes stem cells, immune cells, endothelial progenitor cells, and fibrocytes 
all of which can contribute to healing either structurally or as regulatory influences (Wu et 
al., 2007b). Sublethal whole body irradiation (WBI) therefore requires far less dose than 
skin only irradiation (SI) to delay healing of full thickness incisional wounds in mouse skin 
(Vegesna et al., 1993). In a radiological incident the whole body dose received is therefore 
critical to the assessment of potential deficits in wound healing. The dose received by the 
hematopoietic system may however be very different from that received by the skin due to 
proximity to the radiation source.
In recent years, multiple animal injury models, as well human studies (Garcia-Gomez et al., 
2010), have shown that MSC are excellent candidates for enhancing tissue repair, including 
damage caused by radiation (Leclerc et al., 2011). This is enhanced by reports that they may 
be effective across histocompatibility barriers (Shi et al., 2010), although their true potential 
in this regard is still controversial.
Our approach to correcting radiation-induced wound healing problems using MSC was 
tempered by our previous experience. Based on an earlier study in pigs (Kruegler, 1978.), 
we reported that implanted neonate skin fibroblasts could partly correct radiation-induced 
wound healing deficits in mice (Gorodetsky et al., 1991), findings that Dantzer (Dantzer et 
al., 2003) later extended in a rat model using bone marrow-derived stromal cells. The 
primary factor responsible for our limited success at the time was that cells implanted 
directly into a wound site rapidly disappeared, with <1% remaining for more than a few 
days. To circumvent this problem, we developed a novel fibrin microbead (FMB) cell carrier 
(Gorodetsky, 2008; Gorodetsky et al., 1999; Gorodetsky et al., 2004). Matrix-dependent 
cells including MSC attach to the FMB in 3 dimensional suspension culture, allowing easy 
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removal of the non-attaching hematopoietic and epidermal cells. Attachment is mediated by 
newly described cell binding homologous C-terminal short peptides on β- and γ-chains of 
fibrin, termed haptides (Gorodetsky et al., 1998; Gorodetsky et al., 2003; Levy-Beladev et 
al., 2010). MSC isolated on FMB proliferate to high density (up to 108/ml packed beads) in 
vitro, yielding up to a log more cells than conventional plastic adhesion-based culture 
methods.
When MSC-FMB are implanted in skin wounds in vivo, the FMB degrade slowly and the 
MSC are retained in high numbers to proliferate and differentiate normally within the target 
tissue. Also, FMB can support the viability of MSC for up to 10 days at room temperature, 
making cell transportation easy in emergencies (Gorodetsky et al., 2011).
Here, we use the incisional wound healing model to examine the ability of MSC-FMB to 
correct radiation-induced damage. The ability of MSC-FMB to act across an allogeneic 
barrier was examined, as was the effects of addition of granulocyte colony-stimulating factor 
(G-CSF) and Plerixafor (AMD3100). Finally, the ability of MSC on haptized collagen strips 
to reduce radiation wound healing deficits was assessed.
Results
Dose/time effects of WBI and SI on gain in skin WTS
A dermal wound healing model was established to examine the effect of irradiating the skin 
only with or without total body exposure of the hematopoietic system with the aim of 
examining how different doses to these different organs, as might easily happen in a 
radiological situation, would interact.
Sublethal WBI of C3H mice using gamma rays compromised the ability of wounds in their 
skin to gain WTS by 2 weeks (Fig 1a). After 4 Gy WTS was approximately 10% lower; 
after 6 Gy 20%; and after 8 Gy 30%. These data agree closely with what we found 
previously (Vegesna et al., 1993). In contrast, doses of around 15 Gy 150kVp X-rays to the 
skin only (SI) were required to reduce the gain in WTS by 50% at 2 weeks (Fig 1b), rather 
more than the 13 Gy that we first reported 20 years ago, but considering that the irradiator 
and tensiometer were different, the reproducibility of radiation effects on WTS 
measurements is remarkable.
The gain in WTS with time after radiation was also re-examined. We confirmed our earlier 
finding that WTS increased in unirradiated C3H skin in two phases with nearly half normal 
strength being recovered within 2 weeks (Fig 1c) and 90% by 4–5 weeks (Fig 1c) 
(Gorodetsky et al., 1988). C57Bl/6 skin responded in a very similar manner though with 
slightly higher WTS values (not shown), which could have been due to sex or strain 
differences. The combination of 4 Gy WBI and 21 Gy SI, a scenario that mimics the 
expected scenario of a radiological incident where the skin might be compromised by a high 
dose while the whole body might receive a more moderate dose, resulted in a fairly 
consistent delay of around 10 days to gain the unirradiated level of WTS in C3H mice at 3 
or 4 weeks (Fig 1c). The first “phase” of wound healing is most affected by radiation 
exposure (Gorodetsky et al., 1988), so much so that the 2 week values are too low to be 
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reliable after these doses. We therefore chose to measure the effects of 6Gy WBI and 15Gy 
SI on WTS measured at 4 weeks, the combined WBI and SI deficit in WTS being more than 
additive (Fig 1d).
MSC-FMB compared to plastic adherent MSC populations
FMB were used as a substrate for culture of MSC to allow their rapid purification from 
hematopoietic cells and high-density expansion (Gorodetsky, 2008). Because culture on 
FMB may change the MSC phenotype, we have previously compared the flow cytometric 
profiles of MSC downloaded from FMB to those cultured on plastic (Rivkin et al., 2007) 
using a wide range of putative MSC markers which were more characteristic to a pure 
population of MSC than the plastic isolated cells. For these experiments, the major 
differences were that MSC cultured on FMB (Fig 2a) showed bimodal distributions for 
CD44, CD49e and CD105 with increases in expression of CD49e and CD105. The bimodal 
distribution was largely contributed to by Sca1+, CD44lo, CD49ehi, CD105hi cells of smaller 
size (not shown). CD45+ and CD19+ cells were absent indicating purification from 
hematopoietic cells, which was not the case for cells grown on plastic, while the proportions 
of CD29 and CD31 positive cells were identical in the two populations (Rivkin et al., 2007).
WBI, but not SI, impairs normal cell infiltration into wounds (Vegesna et al., 1993), 
suggesting dependency of optimal wound healing on bone marrow-derived cells and that 
MSC may be a useful therapeutic intervention in combined radiation/wound healing 
scenarios. We considered that FMB-MSC implantation into the wound may additionally 
overcome the rapid loss of cells from the wound site by allowing MSC to download slowly 
from the FMB into the damaged tissue where they could proliferate and differentiate under 
local influences within the wound microenvironment. Importantly, if GFP-MSC from 
transgenic mouse bone marrow that were highly positive for GFP by flow cytometry were 
cultured and implanted on FMB into wounds in WBI+SI treated mice they could be detected 
after 4 days at higher numbers than if they came from plastic adherent cultures (Fig 2c,d). 
Additionally, they integrated in the repaired dermis and persisted for at least 4 weeks post-
implantation in the healing wounds (Fig 2e) when the plastic isolated cells that were injected 
could not be detected.
Syngeneic MSC-FMB correct radiation-induced deficits in WTS
Repeated experiments consistently showed that implantation of FMB devoid of cells did not 
affect the gain in WTS in unirradiated (not shown) or irradiated (Fig 3a) skin. MSC-FMB 
implanted into wounds in SI mice also failed to affect gain in WTS (Fig 3a), as would be 
expected since the infiltrate is still effective. However, MSC-FMB loaded with 
approximately 106 syngeneic cells corrected a 19% WTS total deficit caused by 6 Gy WBI 
by around 80% at 4 weeks (Fig 3a). Pilot experiments showed that although improvement 
was evident at 2 weeks after wounding (not shown), it was markedly less dramatic than at 4 
weeks, suggesting the implanted MSC delivered with FMB proliferated or differentiated in 
the site, as was also suggested by the data shown in Fig 2e.
The efficacy of syngeneic MSC-FMB at reducing the WTS deficit depended upon the 
number of MSC-FMB implanted but not on the strain of mice (Fig 3b,c). If mice were given 
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6 Gy WBI followed immediately by 15 Gy SI, 106 syngeneic MSC-FMB corrected a 39% 
total deficit in C57Bl/6 mice by 49%, and a 35% total deficit in C3H mice by 34% after 4 
weeks of healing. If the dose of MSC-FMB was doubled, the degree of correction increased 
to 71% in both strains. Because of limitations in the volume that can be implanted into an 
incisional wound, it was not possible to test higher numbers of MSC-FMB.
The experimental schedule for the preparation of MSC-FMB was chosen as 2 days of 
rotational culture to allow MSC bone marrow cells to load onto FMB and a further 5 days to 
allow them to proliferate to a high density. While this was a reasonable experimental 
schedule, in an emergency setting a shorter preparation time might be needed. We therefore 
examined the efficacy of MSC-FMB implanted immediately after 2 days loading with 
similar cells loaded and cultured for the additional 5 days in vitro prior to implantation. 
Figure 4a shows that MSC-FMB implanted 2 days after loading were almost as effective in 
reducing radiation-induced wound healing deficits at 4 weeks as MSC that had been 
expanded on FMB in culture for 5 more days, suggesting that MSC proliferate in the wound 
at least as well as they can on FMB in vitro.
Consistent findings in all experiments were that irradiation with WBI and SI prevented hair 
from regrowing in the shaved skin and that, remarkably, MSC-FMB implantation into the 
wound promoted hair regrowth as early as 3 weeks after exposure, although hair color was 
not restored (Fig 4b).
Attempts to improve MSC-FMB efficacy
Our studies clearly showed that syngeneic MSC-FMB implants were effective at correcting 
radiation-induced deficits in wound healing. Since a limitation of an incisional wound 
system is the volume that can be added, we explored in parallel other possible strategies to 
enhance wound healing efficacy in pre-irradiated skin.
Because G-CSF is likely to be given to patients exposed to potentially lethal WBI doses in a 
high dose radiological incident, we examined whether G-CSF treatment of mice with and 
without Plerixafor (AMD3100), which enhances G-CSF-induced mobilization of 
hematopoietic progenitor cells, would assist or detract from MSC-FMB activity in 
correcting radiation-induced WTS deficiencies. MSC-FMB were 20% effective in reducing 
the WTS deficit and this was increased to 29% by in vivo G-CSF treatment and to 46% by 
an additional single injection of Plerixafor given after G-CSF (Fig 5a), indicating that 
hematopoietic mobilization can act in conjunction with MSC-FMB implantation to better 
enhance wound healing.
Additionally, collagen sponge sheets that had been coated haptides, 20mer peptides 
homologous to the cell binding domains on the c-termini of fibrin (“haptized”) (Marx et al., 
2008) were examined as an alternative support structure. These were used to purify MSC 
and were implanted in the bed under the wound, and were highly successful in correcting 
radiation-induced WTS deficits (Fig 5b).
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MSC-FMB implants across an allogeneic barrier
Literature reports indicate that MSC can be immunosuppressive, even to the extent that they 
may be effective across histocompatibility barriers. But contradictory data were also 
presented (English and Mahon, 2011). This could have important clinical consequences in 
radiation settings as autologous MSC might be difficult to obtain from a patient exposed to 
potentially lethal WBI. MSC-FMB that could be administered as a commercial product 
would be ideal for treatment of to a large number of individuals, especially as FMB maintain 
MSC viable for long periods of time without incubation (Gorodetsky et al., 2011). We 
therefore examined the ability of MSC-FMB to reverse radiation-induced wound healing 
deficits across an allogeneic barrier, but only syngeneic MSC were shown to be effective in 
this system (Fig 5c).
Discussion
Exposure to ionizing radiation sets in motion a train of events that can culminate in failure 
of one or multiple organs depending upon many factors, amongst which dose and volume 
are perhaps the most important. As shown in this study and elsewhere, the skin itself is 
moderately resistant to radiation effects (Vegesna et al., 1993; Withers, 1966), but wound 
healing is heavily impacted by modest doses to the whole body that damage the 
hematopoietic system but that are themselves non-lethal (Ran et al., 2004; Vegesna et al., 
1993). WBI decreases the cellular infiltrate into wounds far more than local skin irradiation 
(Vegesna et al., 1993). It is not known which of the many bone marrow-derived cells that 
migrate into the wound site are most affected or the extent to which this effect extends to 
tissue repair in other non-hematopoietic organs (Wu et al., 2007b).
MSC have been a major focus of many recent approaches aimed at improving tissue repair 
and regeneration (Garcia-Gomez et al., 2010) and have been shown to aid wound healing in 
different preclinical models as well as in humans (Chen et al., 2009; Conget et al., 2010; Hu 
et al., 2011; McFarlin et al., 2006; Rogers et al., 2008; Wu et al., 2007a). In bone marrow, 
MSC represent a small fraction of all nucleated cells: less than 0.01% (Bartmann et al., 
2007)
FMB based technology is a convenient, simple and rapid technique to isolate and enrich 
matrix dependent mesenchymal cells that can be applied to tissue regeneration models (Ben-
Ari et al., 2009). One ml of packed FMB can typically bind ~30–70×106 mesenchymal cells. 
Their doubling time at subconfluence in slowly rotating conditions is typically ~48hrs 
(Gorodetsky, 2008, Gorodetsky et al., 2011). Cell binding to FMB seems based on 
interaction of small fibrin domains termed "haptides" with the cell membrane (Gorodetsky et 
al., 2003; Levy-Beladev et al., 2010). Haptides interact with the membranes of different cell 
types but mesenchymal cells once anchored secrete their own extracellular matrix that 
allows them to adhere strongly while other cells of hematopoietic origin are shed during 
rotation. As a result, the populations isolated on FMB are phenotypically purer than those 
isolated on plastic, even if their proportion in the population is originally extremely low, 
(Kassis et al.,;Rivkin et al., 2007). It is notable that in the current study a subpopulation of 
small marker positive MSCs were found that were not seen in populations generated by 
plastic adherence and require further investigation. Multipotency and plasticity are well-
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established features of MSC as is the impact of culture methods, which makes it imperative 
that each system for generating MSC is assessed on its own merits.
For wound healing, FMB provide a protein-based biodegradable support lasting about 2 
weeks in vivo after implantation that carries non-trypsinized intact MSC, retains them in the 
wound site and allows their integration into the ongoing healing processes. MSC-FMB were 
effective in correcting deficits in healing of incisional wounds in mice whose hematopoietic 
system had been compromised by WBI exposure but did little to assist if only the skin was 
irradiated, suggesting that the MSC may have replaced some of the effects of a natural bone 
marrow-derived population that was required for optimal wound healing. This contrasts with 
the recent study by Focheron et al. (2012) who showed that adipose-derived stromal cells 
could heal the skin of minipigs irradiated to 50 Gy which normally would develop necrosis. 
This difference may be ascribed to differences in the dose and model but more likely to the 
fact that our studies on MSC-FMB were somewhat limited by the wound incision model, 
where the area in which therapeutics can be delivered is small. We were however able to 
show that treatment of mice with G-CSF with or without Plerixafor could augment the 
efficacy of MSC-FMB and that haptized collagen sponges are also a promising new delivery 
system for MSC that is not based on whole fibrin protein that may be a more flexible system 
for future investigations. It has been shown in many systems that MSC may function 
indirectly to improve tissue regeneration, and that the effect could be related to modification 
of inflammatory responses (Garcia-Gomez et al., 2010; Chamberlain et al. 2007; Dominici 
et al., 2006; Keyzer et al., 2007). Allogeneic MSC can therefore be effective across 
histocompatibility barriers as they have low immunogenicity and they do not need to survive 
long (Griffin et al., 2010), as they most likely often act by secreting immunosuppressive 
factors (Tolar et al., 2010). In our MSC-FMB system we were unable to demonstrate 
production of immunosuppressive cytokines (not shown) and further experimentation is 
needed to determine if this is an effect of the wound healing/radiation model or of the 
growth promoting FMB culture conditions (Gorodetsky et al., 1998).
An unexpected impressive observation of this investigation was the recovery of hair follicles 
in the high dose irradiated skin as a result of subdermal MSC-FMB implantation into 
irradiated wounds. Hair follicles consist of many different epithelial and mesenchymal cell 
types geared towards the production of hair and may provide an additional source of stem 
cells, which appears in continuity with the basal stem cell layer and that appear to reside in 
the “bulge” region of the follicle shaft (Cotsarelis, 2006; Sun et al., 2007; Yang and 
Cotsarelis, 2010). Since the mesenchymal cells are not expected to trans-differentiate to 
form hair follicles, these findings hint for an indirect secretory effect on these cells on the 
regeneration of a wide range of cell types in the injected area.
Materials and Methods
Mice, Skin Wounds, and Irradiations
C3Hf/Kam (H2-k) female and C57Bl/6 (H2-b) male gnotobiotic mice were used for wound 
healing studies at 8–10 weeks of age. They were bred at UCLA. MSC-GFP were cultured 
from bone marrow from C57Bl/6-Tg(ACTB-EGFP)1Osb/J mice obtained from the Jackson 
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Labs (Maine) and maintained at Hebrew University. All experiments were approved by the 
UCLA IACUC.
WBI was delivered to 8 mice at a time in a well-ventilated Lucite chamber without 
anesthesia using a γ -ray irradiator (137 Cs; AEC) at a dose rate of 67cGy/min. For SI, 150 
kVp/20mA X-rays (Gulmay) and lead shielding were used to reduce the whole body dose. 
Mice were anesthetized with ketamine and xylazine (Bedford, MA) and placed in a lead box 
(1 mm thick) with a flap of dorsal skin pulled through a slit and held loosely using tape. The 
dose rate was 3.623 Gy/min, as determined using thermoluminescent dosimeters on the skin 
surface.
Mice were irradiated one day before wounding (Gorodetsky et al., 1988). WBI plus SI were 
given sequentially with less than 15 minutes in between. Full thickness wounds 
approximately 2.5 cm long were made in the shaved dorsal skin of anesthetized mice 
(Gorodetsky et al., 1988), with ketamine/xylazine as anesthetic. Cells, FMBs and solutions 
were implanted into the wound site in 50 µl volumes. Wounds were closed with 3~4 clips 
which were removed after 2 days. In some experiments 5 μg (micrograms) G-CSF 
(GenScript, NJ) or sterile phosphate-buffered saline (PBS) was given s.c. to C3H mice, once 
a day for 5 days followed on day 6 by 5 mg/kg AMD3100 (Plerixafor; Sigma-Aldrich, MO) 
or PBS.
FMB and MSC
FMB were made from fibrinogen and thrombin as described previously (Gorodetsky et al., 
2004). They were sterilized in 70% ethanol for 8 hours and dried. Meshing was used to 
select FMB with diameters ranging from 108-180µm. Before use they were hydrated in PBS, 
which expands their size by ~50%.
Bone marrow (BM) cells were collected by flushing the femurs and tibias of euthanized 
mice with Minimum Essential Medium (Invitrogen/GIBCO, NY) containing 1% antibiotics 
(penicillin/streptomycin/Amphotericin B; Mediatech, VA). Red cells were lysed using ACK 
buffer (Lonza, Basel, Switzerland) and cells were resuspended in MEM + 20%FBS 
(Invitrogen, Ca.) with antibiotics. For isolation of MSC on plastic, 108 BM cells were plated 
onto 100mm × 20mm plates. After 2 days in culture with 7% CO2 at 37°C, the non-adherent 
cells were rinsed away and the remaining cells expanded for 5 more days with medium 
changes. The enriched population of MSC was harvested using 0.25% trypsin-EDTA 
(Invitrogen, Ca).
For MSC-FMB preparation, 100 μl of sterile hydrated FMB (equivalent to ~50 mg of dry 
FMB) were washed with PBS and mixed with a total of 108 BM cells in culture medium. 
These were put in a 50ml CultiFlask disposable bioreactor tube with vented cap that allowed 
gas exchange and reduced water loss by evaporation (Sartorius Stedim Biotech, Aubagne, 
France). The tube was rotated slowly in ~10–20 rpm at an angle of 20 degree (Gorodetsky et 
al., 2004) for 2 days in an incubator. The non-adherent cells were removed by washing, and 
the MSC-FMB were cultured for another 5 days (unless otherwise indicated) by which time 
the beads were totally covered by MSC. This was confirmed by nuclear count using 
propidium iodide staining performed as described previously (Rivkin et al., 2007). Details of 
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the cell yield, purity, marker expression and other technical issues have been described 
extensively in previous publications (Gorodetsky et al., 1999; Gorodetsky et al., 2004; 
Gorodetsky et al., 2008).
Unless otherwise stated, 15 µl volumes of MSC-FMB in a total of 50 µl PBS containing 
approximately 106 MSC were implanted into each wound prior to its closure.
Flow Cytometry
MSC markers were assessed by flow cytometry as before (Rivkin et al., 2007) 
(FACSCalibur; BD Biosciences, CA). The markers used were CD105, Sca-1, CD44, CD49e 
(Clone 5H10-27, MFR5; BD),CD29, CD45 and CD31.
Collagen Sponges
Highly crosslinked strip sheets of collagen sponge with covalently bound cell binding 20mer 
Haptide sequences (Hapto Biotech, Israel) were sterilized with ethanol 70% for 8 hours, 
rinsed with PBS, and put under a vacuum for 30 minutes. 107 bone marrow cells were 
loaded onto 20mm long collagen sponge strips in 5 ml medium in 50 ml tubes and treated as 
for FMB. After 2 days, the non-adhered cells were rinsed off and after 5 more days of 
incubation, the strips were implanted into the sub dermal area of the wounds. P.I. staining 
confirmed a confluent layer of MSC attached to the collagen substrate.
GFP labeled MSC
For the follow-up of survival and integration of MSC implants in the wounds, MSC were 
isolated from bone marrow of GFP+ C57BL mice by incubation with FMB and implanted 
with FMB to WT C57BL mice.
Tensile Strength Measurement
At stated times after wounding, a square of skin containing the wound was removed from 
euthanized mice and cut into seven 2mm strips of 20mm in length with a multi-blade device 
so that each 2mm wide strip contained a horizontal wound sample (Gorodetsky et al., 1988). 
The strips were spread on filter papers soaked in ice-cold PBS in covered petri dishes till 
WTS measurement as previously described (Gorodetsky 1988) using an Instron tensiometer 
(Model 3342, Instron, Norwood, MA). The skin strips were stretched at a rate of 1 cm/min 
to breaking point to obtain the peak WTS in gram force/2mm.
Since different radiation doses and times are used, for simplicity and comparison between 
experiments, the efficacy of the treatment can be presented as Deficit Reduction (DR), 
which is the reduction in the radiation-induced deficit due to the treatment,
and as Total Deficit (TD):
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Student’s t test was used to assess statistical significance.
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FMB Fibrin MicroBeads
MSC Marrow-Derived Stromal Cells
WTS Wound Tensile Strength
WBI Whole Body Irradiation
SI Skin Only Irradiation
BM Bone Marrow
G-CSF Granulocyte Colony-Stimulating Factor
AMD3100 Plerixafor
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Figure 1. Effects of WBI and SI on wound healing in C3H mice
a) WTS was measured 2 weeks after varying doses of WBI exposure b) WTS measured at 2 
weeks after varying doses of SI exposure. c) The effect of time on gain in WTS was 
assessed in un-irradiated skin (triangles) and skin exposed to 4Gy/WBI + 21Gy/SI (squares). 
WTS measurements at 2 weeks are unreliable within these high SI doses as the first “phase” 
of wound healing is most affected by radiation d) WTS was measured 4 weeks after 6Gy 
WBI or 15Gy SI, or both combined. Error bars indicate mean+/-SEM, n=4. Significance: 
*P<0.05, **P<0.01 by Student’s t-test. (WTS: wound tensile strength; WBI: whole body 
irradiation; SI: Skin only irradiation)
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Figure 2. Phenotypic profile of C57Bl/6 marrow stromal cells –FMB
(a,b) Flow cytometric analysis of MSC markers Sca-1, CD49e, CD44, and CD105 of MSC 
grown on FMB or on plastic c,d) MSC/GFP grown on plastic or loaded on FMB were 
implanted in pre-irradiated wounds in C57Bl/6 mice. Scale bar: 200μm e) Four weeks after 
implantation, MSC/GFP-FMB were still clearly detectable in healing wounds but not in skin 
wounds implanted with MSC isolated and grown on plastic (not shown). Combination of 
fluorescence with dim light to demonstrate the fluorescence with the outline structures of the 
intact skin. Scale bar: 200mm (MSC: Marrow Stromal Cells; FMB: Fibrin Microbeads; 
WBI: whole body irradiation; SI: Skin only irradiation)
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Figure 3. MSC-FMB correct deficits in gain in WTS caused by WBI
a) Syngeneic MSC-FMB were implanted in pre-irradiated C57Bl/6 mice and deficit 
reduction in WTS was assessed after 4 weeks of healing. Mice were exposed to either 18Gy 
SI or to 6Gy WBI. FMB alone were implanted as a control. b) 1×106 MSC-FMB and 2×106 
MSC-FMB were implanted in pre-irradiated wounds of C57Bl/6 and C3H mice. Deficit 
reduction in WTS was assessed after 4 weeks of exposure to 6 Gy/WBI+ 15Gy SI. Error 
bars indicate mean+/−SEM, n=4. Significance: *P<0.05, **P<0.01 by Student’s t-test. 
(WTS: wound tensile strength; WBI: whole body irradiation; SI: Skin only irradiation; 
MSC: Marrow Stromal Cells; FMB: Fibrin Microbeads; TD: Total deficit)
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Figure 4. MSC-FMB implantation times and hair regrowth
a) 1.5×106 MSC-FMB were implanted into C3H mice wounds immediately after 2 days of 
loading onto FMB or after being expanded for a further 5 days in vitro. C3H mice were pre-
irradiated with 4Gy/WBI + 21Gy/SI and WTS was assessed after 4 weeks of healing. Error 
bars indicate mean+/−SEM, n=4. Significance: *P<0.05, **P<0.01 by Student’s t-test. b) 
Skin in C3H mice irradiated with 4Gy/WBI + 21Gy/SI and implanted with MSC-FMB 
regrew hair by 3 weeks after treatment, although color was not restored. (WTS: wound 
tensile strength; MSC: Marrow Stromal Cells; FMB: Fibrin Microbeads; TD: Total deficit)
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Figure 5. Hematopoietic mobilization, collagen sheets and allogeneic and syngeneic MSC
a) Five daily injections of G-CSF were given s.c. to previously wounded C3H mice pre-
irradiated with 4 Gy/WBI+21 Gy/SI. An additional single injection of Plerixafor was 
administrated on day 6 b) MSC on haptized collagen sheets were implanted in the wound of 
C3Hf mice previously exposed to 4Gy/WBI + 21Gy/SI. Deficit reduction in WTS was 
measured 4 weeks after treatment c) C3H and C57Bl/6 mice were exposed to 4Gy/WBI
+21Gy/SI, allogeneic or syngeneic MSC+FMB were implanted in skin wounds, and WTS 
was assessed at 5 weeks. Error bars indicate mean+/−SEM, n=4. Significance: *P<0.05, 
**P<0.01 by Student’s t-test. (WTS: wound tensile strength; MSC: Marrow Stromal Cells; 
FMB: Fibrin Microbeads; G-CSF: granulocyte colony-stimulating factor; TD: Total deficit)
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